BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
+0.095 (6.71%)
At close: Jun 21, 2024, 4:00 PM
+0.050 (3.31%)
After-hours: Jun 21, 2024, 7:18 PM EDT

BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of $72.66 million. The enterprise value is -$6.05 million.

Market Cap 72.66M
Enterprise Value -6.05M

Important Dates

The next estimated earnings date is Tuesday, July 30, 2024, after market close.

Earnings Date Jul 30, 2024
Ex-Dividend Date n/a

Share Statistics

BioAtla has 48.12 million shares outstanding. The number of shares has increased by 1.07% in one year.

Shares Outstanding 48.12M
Shares Change (YoY) +1.07%
Shares Change (QoQ) +0.21%
Owned by Insiders (%) 10.82%
Owned by Institutions (%) 61.33%
Float 35.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.46
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.49, with a Debt / Equity ratio of 0.04.

Current Ratio 4.49
Quick Ratio n/a
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -140.40% and return on invested capital (ROIC) is -242.47%.

Return on Equity (ROE) -140.40%
Return on Assets (ROA) -88.30%
Return on Capital (ROIC) -242.47%
Revenue Per Employee n/a
Profits Per Employee -$1.83M
Employee Count 65
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -60.47% in the last 52 weeks. The beta is 1.07, so BioAtla's price volatility has been similar to the market average.

Beta (1Y) 1.07
52-Week Price Change -60.47%
50-Day Moving Average 2.27
200-Day Moving Average 2.20
Relative Strength Index (RSI) 37.65
Average Volume (20 Days) 698,842

Short Selling Information

The latest short interest is 5.40 million, so 11.22% of the outstanding shares have been sold short.

Short Interest 5.40M
Short Previous Month 5.20M
Short % of Shares Out 11.22%
Short % of Float 15.08%
Short Ratio (days to cover) 6.45

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -125.21M
Pretax Income -119.24M
Net Income -119.24M
EBITDA -118.07M
EBIT -119.24M
Earnings Per Share (EPS) -$2.49
Full Income Statement

Balance Sheet

The company has $80.63 million in cash and $1.92 million in debt, giving a net cash position of $78.71 million or $1.64 per share.

Cash & Cash Equivalents 80.63M
Total Debt 1.92M
Net Cash 78.71M
Net Cash Per Share $1.64
Equity / Book Value 49.72M
Book Value Per Share 1.03
Working Capital 67.17M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$112.19 million and capital expenditures -$48,000, giving a free cash flow of -$112.24 million.

Operating Cash Flow -112.19M
Capital Expenditures -48,000
Free Cash Flow -112.24M
FCF Per Share -$2.33
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.07%
Shareholder Yield -1.07%
Earnings Yield -164.11%
FCF Yield -154.48%

Analyst Forecast

The average price target for BioAtla is $12.75, which is 744.37% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.75
Price Target Difference 744.37%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -21.90%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 2